Evidence map›Paper›PMID 40382747›Full record

ArticleArchives of toxicology2025

In vitro CB

Henrik Green, Craig McKenzie, Elias Hamra, Tobias Rautio, Xiongyu Wu, Emma Juneskog, Rebecka Sandblom, Manuela Carla Monti, Mattias Persson, Caitlyn Norman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Henrik GreenDepartment of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden.ORCID 0000-0002-8015-5728
Craig McKenzieChiron AS, Trondheim, Norway.ORCID 0000-0001-7244-5779
Elias HamraDepartment of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden.
Tobias RautioDepartment of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.ORCID 0000-0002-0857-6261
Xiongyu WuDepartment of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.ORCID 0000-0001-6756-2276
Emma JuneskogDepartment of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden.
Rebecka SandblomDepartment of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden.
Manuela Carla MontiDepartment of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden.ORCID 0000-0002-9959-398X
Mattias PerssonDepartment of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden.ORCID 0000-0002-4383-2902
Caitlyn NormanDepartment of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden. caitlyn.norman@liu.se.ORCID 0000-0003-2322-0367

Funding

Eurostars E!2297Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 217677VINNOVA 2019-03566
6 · The paper itself

Abstract

Synthetic cannabinoid receptor agonists (SCRAs) are a group of new psychoactive substances (NPS) that bind to and activate the cannabinoid 1 and 2 (CB

Indexed as

Cannabinoid Receptor AgonistsIndazolesReceptor, Cannabinoid, CB1AnimalsCHO CellsHalogenationHumansStructure-Activity RelationshipCannabinoid Receptor AgonistsIndazolesReceptor, Cannabinoid, CB1CB1 cannabinoid receptorHalogenated synthetic cannabinoid receptor agonistsNew psychoactive substancesPotencyStructure–activity relationships

Identifiers

PMID40382747
PMCPMC12367851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.